National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting, 62814-62815 [2011-26219]
Download as PDF
<![CDATA[
62814
Federal Register / Vol. 76, No. 196 / Tuesday, October 11, 2011 / Notices
describing the best test methods for
proprietary name evaluation.
II. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) either electronic or written
comments regarding the pilot project or
this document. It is only necessary to
send one set of comments. It is no
longer necessary to send two copies of
mailed comments. Identify comments
with the docket number found in
brackets in the heading of this
document. Received comments may be
seen in the Division of Dockets
Management between 9 a.m. and 4 p.m.,
Monday through Friday.
Dated: October 4, 2011.
David Dorsey,
Acting Associate Commissioner for Policy and
Planning.
[FR Doc. 2011–26099 Filed 10–7–11; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Council on Blood Stem Cell
Transplantation; Notice of Meeting
mstockstill on DSK4VPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Public Law 92–463), notice is hereby
given of the following meeting:
Name: Advisory Council on Blood Stem
Cell Transplantation (ACBSCT).
Date and Time: November 08, 2011, 10 am
to 4 pm EDT.
Place: The meeting will be via audio
conference call and Adobe Connect Pro.
Status: The meeting will be open to the
public.
Purpose: Pursuant to Public Law 109–129,
42 U.S.C. 274k (section 379 of the Public
Health Service Act, as amended,) the
Advisory Council on Blood Stem Cell
Transplantation (ACBSCT) advises the
Secretary of HHS and the Administrator,
HRSA, on matters related to the activities of
the C.W. Bill Young Cell Transplantation
Program (Program) and the National Cord
Blood Inventory (NCBI) Program.
Agenda: The Council will hear reports
from five ACBSCT Work Groups: Cord Blood
Bank Collections, Realizing the Potential of
Cord Blood, Scientific Factors Necessary to
Define a Cord Blood Unit as High Quality,
Cord Blood Thawing and Washing, and
Access to Transplantation. The Council also
will hear presentations and discussions,
which may include the following topics:
CAO study and report; FDA licensure and
unmet need.
The public can join the meeting by:
1. Calling Conference Phone Number: 888–
790–3527 and providing Participant Code:
8064893, for the audio portion, AND
VerDate Mar<15>2010
20:47 Oct 07, 2011
Jkt 226001
2. Connecting to the ACBSCT Adobe
Connect Pro Meeting for the visual portion
using the following URL: https://
hrsa.connectsolutions.com/acbsct/ (if the
link does not work, copy and paste it into
your browser). The conference call leader is
Patricia A. Stroup.
Call (301) 443–0437 or send an e-mail to
ptongele@hrsa.com if you are having trouble
connecting to the meeting site.
Participants should call no later than 9:45
am EDT in order for logistics to be set up.
If you have never attended an Adobe Pro
Connect Meeting, please test your connection
using the following URL: https://hrsa.connect
solutions.com/common/help/en/support/
meeting_test.htm.
For quick overview, please access: https://
www.adobe.com/go/connectpro_overview.
Those planning to participate are asked to
complete and submit an online registration
form by visiting our Web site at https://
www.ACBSCT.com and selecting the tab
titled ‘‘Registration.’’ Individuals with no
Internet access should request the
registration form by contacting Gabrielle
Kardolus at (301) 585–1261 or at
Gabrielle.Kardolus@luxcg.com and fax the
registration form to Gabrielle Kardolus at
(301) 585–7741. The registration deadline is
November 2, 2011. The next face-to-face
ACBSCT meeting is planned for Spring 2012.
Details regarding the next meeting will be
published in a subsequent Federal Register
notice.
Public Comment: Persons interested in
providing an oral presentation should submit
a written request, along with a copy of their
presentation to: Passy Tongele, DoT,
Healthcare Systems Bureau (HSB), Health
Resources and Services Administration
(HRSA), Room 12C–06, 5600 Fishers Lane,
Rockville, Maryland 20857 or e-mail:
ptongele@hrsa.gov. Requests should contain
the name, address, telephone number, e-mail
address, and any business or professional
affiliation of the person desiring to make an
oral presentation. Groups having similar
interests are requested to combine their
comments and present them through a single
representative. The allocation of time may be
adjusted to accommodate the level of
expressed interest. Persons who do not file
an advance request for a presentation, but
desire to make an oral statement, may
announce it at the time of the public
comment period. Public participation and
ability to comment will be limited to space
and time as it permits.
For Further Information Contact: Patricia
Stroup, Executive Secretary, Healthcare
Systems Bureau, Health Resources and
Services Administration, 5600 Fishers Lane,
Room 12C–06, Rockville, Maryland 20857;
telephone (301) 443–1127.
Dated: October 3, 2011.
Reva Harris,
Acting Director, Division of Policy and
Information Coordination.
[FR Doc. 2011–26168 Filed 10–7–11; 8:45 am]
BILLING CODE 4165–15–P
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center For Research
Resources; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Research Resources Special Emphasis Panel.
Date: November 9, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Rockville, 1750 Rockville
Pike, Rockville, MD 20852.
Contact Person: Martha F. Matocha, PhD,
Scientific Review Officer, Office of Review,
National Center for Research Resources,
National Institutes of Health, 6701
Democracy Blvd., 1 Democracy Plaza, Rm.
1070, Bethesda, MD 20892, 301–435–0813,
matocham@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure,
93.306, 93.333; 93.702, ARRA Related
Construction Awards., National Institutes of
Health, HHS)
Dated: October 4, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–26218 Filed 10–7–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
E:\FR\FM\11OCN1.SGM
11OCN1
Federal Register / Vol. 76, No. 196 / Tuesday, October 11, 2011 / Notices
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel, 2012–01 NIBIB R13
Conference Grant Review.
Date: November 14, 2011.
Time: 11 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health/NIBIB,
DEM II, 6707 Democracy Blvd., 223,
Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Ruixia Zhou, PhD,
Scientific Review Officer, 6707 Democracy
Boulevard, Democracy Two Building, Suite
957, Bethesda, MD 20892, 301–496–4773,
zhour@mail.nih.gov.
Dated: October 4, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy And
Infectious Diseases; Notice of Closed
Meeting
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, NIH/PEPFAR Collaboration
for Implementation Science and Impact
Evaluation.
Date: December 5, 2011.
Time: 9 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
20:47 Oct 07, 2011
Jkt 226001
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: October 4, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–26210 Filed 10–7–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: October 4, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2011–26212 Filed 10–7–11; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences Notice of Closed Meeting
[FR Doc. 2011–26219 Filed 10–7–11; 8:45 am]
VerDate Mar<15>2010
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Dharmendar Rathore, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 6700B
Rockledge Drive, MSC 7616, Rm 3134,
Bethesda, MD 20892–7616, 301–435–2766,
rathored@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
62815
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, MBRS Score.
Date: November 7, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Saraswathy Seetharam,
PhD, Scientific Review Officer, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3AN12C,
Bethesda, MD 20892, 301–594–2763,
seetharams@nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
PO 00000
Frm 00061
Fmt 4703
Sfmt 9990
National Institute of General Medical
Sciences; Notice of Closed Meeting
Name of Committee: National Institute of
General Medical Sciences Initial Review
Group, Minority Programs Review
Subcommittee B.
Date: November 7, 2011.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Courtyard Chevy Chase,
5520 Wisconsin Avenue, Chevy Chase, MD
20815.
Contact Person: Rebecca H. Johnson, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN18C, Bethesda, MD
20892, 301–594–2771, johnsonrh@nigms.nih.
gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: October 4, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–26206 Filed 10–7–11; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\11OCN1.SGM
11OCN1
]]>Agencies
[Federal Register Volume 76, Number 196 (Tuesday, October 11, 2011)]
[Notices]
[Pages 62814-62815]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-26219]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections
[[Page 62815]]
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant
applications and the discussions could disclose confidential trade
secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel, 2012-01 NIBIB R13 Conference
Grant Review.
Date: November 14, 2011.
Time: 11 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health/NIBIB, DEM II, 6707
Democracy Blvd., 223, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Ruixia Zhou, PhD, Scientific Review Officer,
6707 Democracy Boulevard, Democracy Two Building, Suite 957,
Bethesda, MD 20892, 301-496-4773, zhour@mail.nih.gov.
Dated: October 4, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-26219 Filed 10-7-11; 8:45 am]
BILLING CODE 4140-01-P
